LucieFournier

Associate

Brussels + 32.2.645.15.47

Connect:

Share

Lucie Fournier works on European data protection and cybersecurity law, with a focus on implementing EU General Data Protection Regulation (GDPR) and ePrivacy Regulation (ePR) compliance. She advises multinational clients in various industry sectors such as automotive, agribusiness, IT, and life sciences.

Lucie also advises clients on data protection issues in cross-border M&A transactions and assists clients on data processing agreements and legal mechanisms for the international transfer of personal data.

Prior to joining Jones Day, Lucie completed legal traineeships at the French Ministry of Defense and in the intellectual property and IT department of a U.S. law firm in Paris. She also has in-house experience as a legal adviser at a UK multinational company that focuses on defense, aerospace, and cybersecurity.

Experience

  • Bombardier to sell transportation business to Alstom for €6.2 billionJones Day is serving as antitrust and French corporate counsel in the €6.2 billion sale of Bombardier Inc.'s transportation business to Alstom S.A.
  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • ICON acquires Symphony Clinical ResearchJones Day advised ICON plc as health care, clinical trial regulatory, and data privacy diligence counsel in its acquisition of Symphony Clinical Research, a leading provider of at-home patient and site support services.
  • Arsenal Capital Partners acquires HistoGeneX and Caprion BiosciencesJones Day advised Arsenal Capital Partners on major investments in HistoGeneX and Caprion Biosciences and the subsequent combination of the two businesses.
  • Evidera acquires MedimixJones Day advised Evidera, a business unit of Pharmaceutical Product Development, LLC, in its acquisition of Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic, and medical device industries.
    • View All

    January 2020 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2020

    June 2019 Commentaries

    The EU Cybersecurity Act is Now Applicable

    March 2019 Jones Day Publications

    Jones Day Global Privacy & Cybersecurity Update | Vol. 21
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.